Leveraging Quitlines for Tobacco Cessation: Real-World Implementation

Duration:

75 Minutes

Webinar Speakers

Michael C. Fiore, MD, MPH, MBA

University of Wisconsin Hilldale Professor of Medicine, Director, Center for Tobacco Research and Intervention (UW-CTRI), University of Wisconsin School of Medicine and Public Health

Michael Fiore, University of Wisconsin Hilldale Professor of Medicine, founded and has served as Director of the University of Wisconsin Center for Tobacco Research and Intervention (UW-CTRI) since it was established in 1992. Fiore served as chair of the panels that produced the United States Public Health Service (PHS) Clinical Practice Guidelines: Treating Tobacco Use and Dependence in 1996, 2000, and 2008. Dr. Fiore chaired the U.S. Department of Health and Human Services Subcommittee on Tobacco Cessation of the Interagency Committee on Smoking and Health that produced a comprehensive plan for promoting tobacco cessation in the United States. In 2005, Dr. Fiore was asked by the United States Justice Department as part of their landmark lawsuit against the tobacco industry to craft a $130 billion, 25-year plan to assist 33 million smokers to quit. During his long and distinguished medical and public health career at the University of Wisconsin-Madison, he has served as Principal Investigator on five consecutive NIH Center grants and was an inaugural recipient of a National Cancer Institute Outstanding Investigator Award (R35) in 2015. He is the recipient of numerous awards and honors. In 2012, he was elected to the National Academy of Medicine (formerly, Institute of Medicine).

Joann Yoon Kang, JD

Team Lead, Health Systems and Data Visualization, Policy Unit of the Office on Smoking and Health (OSH) at the Centers for Disease Control and Prevention (CDC)

Joann Kang is the Team Lead for Health Systems and Data Visualization, which is housed in the Policy Unit of the Office on Smoking and Health (OSH) at the Centers for Disease Control and Prevention (CDC). In this capacity, Joann provides leadership to inform development and implementation of health systems strategies to increase tobacco cessation. In addition, she also oversees legal analysis and publication of state legislation pertaining to tobacco control and prevention.

Joann has been with CDC since 2012. Her cumulative experience while working at the Agency has included serving as a liaison with Congressional offices, establishing and strengthening partnerships with both federal and external organizations, budget formulation, project management on health policy initiatives, and helping to inform the Agency’s response to the nation’s opioid overdose epidemic.

As a member of the State Bar of Georgia, Joann began her career as an attorney—first as a Pro Bono Fellow in a private law firm and then serving as a staff attorney with a non-profit, medical-legal collaborative representing children and their families. Following her legal work, Joann worked as a policy analyst and lobbyist on children’s health issues with a Georgia-based non-profit policy and advocacy organization.

Joann received her B.S. in Advertising from the University of Illinois at Urbana-Champaign and her J.D. from Emory University School of Law.

Chad D Morris, PhD

Clinical Psychologist and Professor of Psychiatry at the University of Colorado- School of Medicine, and the Director of the Behavioral Health & Wellness Program and Wellness Leadership Institute

Chad Morris, Ph.D. is a clinical psychologist and Professor of Psychiatry at the University of Colorado- School of Medicine. At CU he is the Director of the Behavioral Health & Wellness Program and Wellness Leadership Institute. He is the principal investigator of over 100 projects and studies exploring the effectiveness of organizational, psychosocial, and pharmacologic whole health and tobacco cessation strategies across over 40 states and internationally. His work has focused on the needs of persons with mental illnesses and addictions, individuals who are homeless or at risk for homelessness, justice involved individuals, pregnant and perinatal mothers, rural and frontier residents, and at-risk youth. Dr. Morris also specializes on the work and well-being of interdisciplinary professionals. Dr. Morris is a seasoned Motivational Interviewing trainer and member of the MI Network of Trainers (MINT). As the Vice President of Spark Inspiration, Dr. Morris also offers corporate wellness solutions.

Webinar Objectives
  • Identify ways in which Quitlines have evolved since their inception
  • Identify how the reach of quitlines can be enhanced through media campaigns that promote quit services
  • Examine the processes associated with implementing eReferral to the Quitline in primary care health settings
  • Analyze the impact of quitline eReferral for various subpopulations
  • Demonstrate how quitlines are tailoring services to meet the needs of callers with behavioral health conditions
  • Analyze initial outcomes for tailored quitline programs
Instructions for CME/CEU Credit

CME/CEU registration has closed for this live activity. Credit will be available for the recorded version by the end of the year.

 

Certificates of Attendance

 

Click here to generate a certificate of attendance for participating on this webinar.

 

ACCME Accreditation

The University of California, San Francisco (UCSF) School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

UCSF designates this live activity for a maximum of 1.25 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the webinar activity.

Advance Practice Registered Nurses and Registered Nurses: For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 CreditTM issued by organizations accredited by the ACCME.

Physician Assistants: The National Commission on Certification of Physician Assistants (NCCPA) states that the AMA PRA Category 1 CreditTM are acceptable for continuing medical education requirements for recertification.

California Pharmacists: The California Board of Pharmacy accepts as continuing professional education those courses that meet the standard of relevance to pharmacy practice and have been approved for AMA PRA category 1 CreditTM. If you are a pharmacist in another state, you should check with your state board for approval of this credit.

California Psychologists: The California Board of Psychology recognizes and accepts for continuing education credit courses that are provided by entities approved by the Accreditation Council for Continuing Medical Education (ACCME). AMA PRA Category 1 CreditTM is acceptable to meeting the CE requirements for the California Board of Psychology. Providers in other states should check with their state boards for acceptance of CME credit.

California Behavioral Science Professionals: University of California, San Francisco School of Medicine (UCSF) is approved by the California Association of Marriage and Family Therapists to sponsor continuing education for behavioral health providers. UCSF maintains responsibility for this program/course and its content.

Course meets the qualifications for 1.25 hours of continuing education credit for LMFTs, LCSWs, LPCCs, and/or LEPs as required by the California Board of Behavioral Sciences. Provider # 64239.

ACCREDITATION FOR CALIFORNIA ADDICTION COUNSELORS

The UCSF office of continuing medical education is accredited by the California Consortium of Addiction Programs and Professionals (CCAPP), to provide continuing education credit for California addiction counselors. UCSF designates this live, virtual activity, for a maximum of 1.25 CCAPP credits. Addiction counselors should claim only the credit commensurate with the extent of their participation in the activity. Provider number: 7-20-322-0722.

 

Disclosures

This UCSF CME activity was planned and developed to uphold academic standards to ensure balance, independence, objectivity, and scientific rigor; adhere to requirements to protect health information under the Health Insurance Portability and Accountability Act of 1996 (HIPAA); and include a mechanism to inform learners when unapproved or unlabeled uses of therapeutic products or agents are discussed or referenced.

The following speakers, moderators and planning committee members have disclosed they have no financial interest/arrangement or affiliation with any commercial companies who have provided products or services relating to their presentation(s) or commercial support for this continuing medical education activity:

Anita Browning, Christine Cheng, Brian Clark, Michael C. Fiore, MD, MPH, MBA, Joann Yoon Kang, JD, Jennifer Matekuare, Chad Morris, PhD, Ma Krisanta Pamatmat, MPH, Jessica Safier, MA, Catherine Saucedo, Steven A. Schroeder, MD, and Aria Yow, MA.